Skip to main content
. 2007 May 21;5(1):24–30. doi: 10.1111/j.1524-6175.2003.01246.x

Table II.

Target Organ Abnormalities

Entire Cohort Not On Medication at Baseline On Medication at Baseline: Not Controlled On Medication at Baseline: Controlled
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Left ventricular hypertrophy (n=278 for echo; n=301 for ECG)
  Echo LVM (g) 211 (68) 210 (67) 223 (73) 192 (58)
  Echo LVM/ht2.7 45.9 (14.6) 45.3 (13.7) 48.0 (15.2) 43.6 (15.4)
  Echo LVM/BSA 108 (35) 108 (35) 112 (36) 100 (31)
  Echo LVH % (LVM/ht2.7) 30% 29% 37% 21%
  Echo LVH % (LVM/BSA) 25% 26% 30% 14%
  ECG sum Cornell voltage 18.4 (9.0) 18.0 (8.3) 20.2 (9.1) 15.7 (9.7)
  ECG LVH Cornell voltage % 12% 11% 18% 4%
  ECG strain pattern 3% 4% 5% 0
Nonspecific T wave abnormality
  Major 15% 16% 17% 9%
  Minor 18% 13% 26% 16%
Diastolic function (n=284)
  E wave velocity (cm/sec) 69 (16) 69 (14) 68 (17) 70 (16)
  A wave velocity (cm/sec) 64 (13) 62 (13) 65 (14) 65 (12)
  E/A wave ratio 1.1 (0.3) 1.15 (0.33) 1.08 (0.29) 1.10 (0.30)
  Deceleration time (msec) 202 (68) 198 (68) 202 (71) 211 (62)
  E/A ratio <1.0 38% 33% 45% 39%
  Deceleration time >240 msec 25% 21% 27% 29%
Systolic function (n=248)
  Ejection fraction 69 (13) 68 (13) 68 (14) 71 (8)
  Ejection fraction <50% 7% 8% 10% 0%
Renal function (n=298 for serum; n=281 for urine)
  Serum creatinine (mg/dL) 1.3 (0.9) 1.2 (0.8) 1.4 (0.9) 1.3 (1.0)
  Creatinine >1.6 (mg/dL) 10% 7% 14% 11%
  Urine Cr Cl (mL/min/1.73 m2) 102 (37) 102 (34) 103 (42) 99 (32)
  Cr Cl <60 (mL/min/1.73 m2) 9% 7% 10% 11%
  Urine albumin/creatinine ratio 187 (569) 125 (451) 262 (697) 210 (571)
  Microalbuminuria (%) 21% 21% 24% 15%
  Gross proteinuria (%) 13% 8% 20% 13%
  Proteinuria (%) 34% 29% 42% 28%
echo=echocardiography; LVM=left ventricular mass; ECG=electrocardiography; BSA=body surface area; LVH=left ventricular hypertrophy; Cr Cl=creatinine clearance